Latest Non Dilutive Funding News

Thor Energy has completed the sale of a 75% stake in its US uranium and vanadium projects to Metals One PLC, receiving £1 million in shares and a cash exclusivity payment. This deal allows Thor to focus on its hydrogen and helium ambitions while Metals One takes operational control.

Tryptamine Therapeutics has locked in $2.6 million in non-dilutive funding to fast-track clinical trials of its lead psilocin-based therapy, TRP-8803, targeting binge eating disorder and other conditions.

Iondrive Limited has won a $3.9 million government grant to advance its innovative urban mining technology, accelerating the construction of a pilot plant focused on critical minerals recovery from lithium-ion batteries.

SRJ Technologies clarifies its financial position and strategic rationale behind a recent capital raise and acquisition of a UAE entity, addressing ASX concerns over its viability and voluntary suspension.

HeraMED advances AI-driven maternity care partnerships and strengthens its US commercial team, navigating policy uncertainties while progressing its global expansion and funding strategies.

Perpetual Resources has reported a successful maiden drilling campaign at its Igrejinha Project in Brazil, intersecting a significant 200m lithium-caesium pegmatite body. The company also advances its rare earths exploration at the Raptor Project, supported by a recent $500,000 capital raise.

International Graphite Limited (ASX, IG6) has signed a cooperation agreement to develop a 3,000 t/y expandable graphite facility in Germany, advancing its global footprint alongside progress at its Collie micronising plant and Springdale project, supported by potential US Department of Defense funding.

Cadoux Limited has made significant progress in developing its high purity alumina and rare earths projects, advancing engineering design, customer engagement, and funding strategies during the June 2025 quarter.

Rhythm Biosciences has successfully validated its ColoSTAT® colorectal cancer test, secured its first strategic partnership for Genetype, and secured $1 million in non-dilutive funding, setting the stage for a transformative FY26.

Everest Metals Corporation has revealed a promising 1.1km gold anomaly at its Revere project, completed a key rubidium extraction study at Mt Edon, and is poised to start mining at Mt Dimer by year-end.

Latitude 66 Limited has agreed to sell its 17.5% interest in the Greater Duchess Copper Gold Joint Venture to Carnaby Resources for A$6 million, combining cash and shares. This strategic move frees up capital for Lat66 to focus on its exploration projects in Western Australia and Finland.

Sun Silver Limited reports breakthrough high-grade silver-gold intercepts at Maverick Springs alongside a $30 million capital raise to accelerate exploration and development.